{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:02:15Z","timestamp":1786114935510,"version":"build-2736575974"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Bardet-Biedl syndrome (BBS) carries early cardiometabolic risk, yet pediatric screening is complicated by growth and puberty. The metabolic syndrome (MetS) z-score provides a continuous benchmark for clustered risk. The single-point insulin sensitivity estimator (SPISE), based on body mass index (BMI) and fasting lipids, may offer a practical alternative where insulin testing is impractical. We aimed to assess the association between SPISE and cardiometabolic burden in children with molecularly confirmed BBS, and to compare its ability to identify MetS against the MetS z-score benchmark and insulin-derived indices.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Single-center retrospective pilot study including children\/adolescents with genetically confirmed BBS who underwent standardized anthropometry and metabolic profiling (fasting lipids, glucose, insulin; OGTT when available). SPISE\u2013MetS z-score associations were examined using Spearman and adjusted analyses. In adolescents (\u2265\u200910 years), MetS discrimination was evaluated with ROC curves for SPISE, TG\/HDL, and homeostatic model assessment for insulin resistance (HOMA-IR), with pairwise DeLong comparisons and Youden-optimal thresholds.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Fourteen participants (7 females, 7 males) were evaluated. Median age at last visit was 11.7 years [IQR 7.6\u201315.5]; BMI SDS was 3.05 [2.47\u20133.57]. The median MetS z-score was 1.60 [0.90\u20131.75]. SPISE correlated inversely with the MetS z-score (\u03c1=-0.57,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.021), and adjusted models (age, sex, BMI-SDS) retained significance. Among adolescents (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200910), SPISE showed the highest AUC for MetS (AUC 0.95; 95% CI 0.82\u20131.00) versus TG\/HDL (AUC 0.81) and HOMA-IR (AUC 0.60); pairwise differences were not statistically significant. Youden-optimal SPISE\u2009\u2264\u20093.34 identified MetS with high sensitivity in adolescents. Confidence intervals were wide, reflecting the small sample size.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In this single-center pediatric BBS cohort, SPISE tracked continuous MetS burden and showed numerically stronger discrimination for MetS than insulin-derived indices. These findings highlight the potential utility of SPISE as a feasible tool for cardiometabolic monitoring in syndromic obesity, where laboratory access may be limited. Beyond BBS, SPISE may support early risk stratification and follow-up in rare obesity models of metabolic risk, but multicenter prospective validation remains warranted.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13023-026-04353-y","type":"journal-article","created":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T23:26:30Z","timestamp":1785972390000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Assessment of cardiometabolic risk using single point insulin sensitivity estimator (SPISE) in pediatric Bardet\u2013Biedl Syndrome: a pilot study"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1561-2862","authenticated-orcid":false,"given":"Tugce","family":"Kandemir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6603-2983","authenticated-orcid":false,"given":"Melek","family":"Yildiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3240-3408","authenticated-orcid":false,"given":"Ummahan","family":"Tercan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7780-0231","authenticated-orcid":false,"given":"Ozge Bayrak","family":"Demirel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9986-6423","authenticated-orcid":false,"given":"Hasan","family":"Yanik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8777-3548","authenticated-orcid":false,"given":"Volkan","family":"Karaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1770-1762","authenticated-orcid":false,"given":"Ayca Dilruba","family":"Aslanger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0594-8741","authenticated-orcid":false,"given":"Asl\u0131 Derya","family":"Kardelen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6806-9678","authenticated-orcid":false,"given":"Sukran","family":"Poyrazoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4786-0780","authenticated-orcid":false,"given":"Feyza","family":"Darendeliler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8103-9980","authenticated-orcid":false,"given":"Guven","family":"Toksoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9689-4464","authenticated-orcid":false,"given":"Firdevs","family":"Bas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,6]]},"reference":[{"issue":"3","key":"4353_CR1","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/0022-510x(69)90091-4","volume":"9","author":"D Klein","year":"1969","unstructured":"Klein D, Ammann F. The syndrome of Laurence-Moon-Bardet-Biedl and allied diseases in Switzerland: clinical, genetic and epidemiological studies. J Neurol Sci. 1969;9(3):479\u2013513. https:\/\/doi.org\/10.1016\/0022-510x(69)90091-4.","journal-title":"J Neurol Sci"},{"issue":"2","key":"4353_CR2","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1136\/jmg.34.2.92","volume":"34","author":"PL Beales","year":"1997","unstructured":"Beales PL, Warner AM, Hitman GA, Thakker R, Flinter FA. Bardet-Biedl syndrome: a molecular and phenotypic study of 18 families. J Med Genet. 1997;34(2):92\u20138. https:\/\/doi.org\/10.1136\/jmg.34.2.92.","journal-title":"J Med Genet"},{"key":"4353_CR3","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.2147\/JMDH.S274739","volume":"15","author":"L Caba","year":"2022","unstructured":"Caba L, Florea L, Braha EE, Lupu VV, Gorduza EV. Monitoring and management of Bardet-Biedl syndrome: what the multi-disciplinary team can do. J Multidiscip Healthc. 2022;15:2153\u201367. https:\/\/doi.org\/10.2147\/JMDH.S274739.","journal-title":"J Multidiscip Healthc"},{"issue":"5","key":"4353_CR4","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1210\/jc.2017-01459","volume":"103","author":"S Mujahid","year":"2018","unstructured":"Mujahid S, Hunt KF, Cheah YS, Forsythe E, Hazlehurst JM, Sparks K, et al. The endocrine and metabolic characteristics of a large Bardet-Biedl syndrome clinic population. J Clin Endocrinol Metab. 2018;103(5):1834\u201341. https:\/\/doi.org\/10.1210\/jc.2017-01459.","journal-title":"J Clin Endocrinol Metab"},{"key":"4353_CR5","doi-asserted-by":"publisher","first-page":"3489","DOI":"10.2147\/DMSO.S430360","volume":"16","author":"JL D\u00edaz-Ortega","year":"2023","unstructured":"D\u00edaz-Ortega JL, Yupari-Azabache IL, Caballero Vidal JA, Conde-Parada NE, Rojas Gamboa AF. Criteria in the diagnosis of metabolic syndrome in children: a scoping review. Diabetes Metab Syndr Obes. 2023;16:3489\u2013500. https:\/\/doi.org\/10.2147\/DMSO.S430360.","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"5","key":"4353_CR6","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1111\/j.1399-5448.2007.00271.x","volume":"8","author":"P Zimmet","year":"2007","unstructured":"Zimmet P, Alberti KG, Kaufman F, Tajima N, Silink M, Arslanian S, et al. The metabolic syndrome in children and adolescents: an IDF consensus report. Pediatr Diabetes. 2007;8(5):299\u2013306. https:\/\/doi.org\/10.1111\/j.1399-5448.2007.00271.x.","journal-title":"Pediatr Diabetes"},{"issue":"5","key":"4353_CR7","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1097\/MPG.0b013e318252a13f]","volume":"54","author":"P Vajro","year":"2012","unstructured":"Vajro P, Lenta S, Socha P, Dhawan A, McKiernan P, Baumann U, et al. Diagnosis of nonalcoholic fatty liver disease in children and adolescents: position paper of the ESPGHAN Hepatology Committee. J Pediatr Gastroenterol Nutr. 2012;54(5):700\u201313. https:\/\/doi.org\/10.1097\/MPG.0b013e318252a13f].","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"4353_CR8","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1161\/HYPERTENSIONAHA.117.10010","volume":"70","author":"JT Flynn","year":"2017","unstructured":"Flynn JT, Falkner BE. New clinical practice guideline for the management of high blood pressure in children and adolescents. Hypertension. 2017;70:683\u20136. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.117.10010.","journal-title":"Hypertension"},{"key":"4353_CR9","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1161\/HYP.0000000000000065","volume":"71","author":"PK Whelton","year":"2018","unstructured":"Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Dennison Himmelfarb C, et al. Guideline for the management of high blood pressure in adults. Hypertension. 2018;71:1269\u2013324. https:\/\/doi.org\/10.1161\/HYP.0000000000000065.","journal-title":"Hypertension"},{"key":"4353_CR10","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.jpeds.2016.06.015","volume":"177","author":"MJ Gurka","year":"2016","unstructured":"Gurka MJ, Ice CL, Sun SS, Deboer MD. Metabolic syndrome severity score: a tool to quantify pediatric metabolic syndrome and predict future risk. J Pediatr. 2016;177:33\u20139. https:\/\/doi.org\/10.1016\/j.jpeds.2016.06.015.","journal-title":"J Pediatr"},{"key":"4353_CR11","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/1475-2840-11-128","volume":"11","author":"MJ Gurka","year":"2012","unstructured":"Gurka MJ, Ice CL, Sun SS, Deboer MD. Confirmatory factor analysis of the metabolic syndrome in adolescents. Cardiovasc Diabetol. 2012;11:128. https:\/\/doi.org\/10.1186\/1475-2840-11-128.","journal-title":"Cardiovasc Diabetol"},{"key":"4353_CR12","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/BF00280883","volume":"28","author":"DR Matthews","year":"1985","unstructured":"Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment. Diabetologia. 1985;28:412\u20139. https:\/\/doi.org\/10.1007\/BF00280883.","journal-title":"Diabetologia"},{"issue":"3","key":"4353_CR13","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/S1521-690X(03)00042-3","volume":"17","author":"G Pacini","year":"2003","unstructured":"Pacini G, Mari A. Methods for clinical assessment of insulin sensitivity and \u03b2-cell function. Best Pract Res Clin Endocrinol Metab. 2003;17(3):305\u201322. https:\/\/doi.org\/10.1016\/S1521-690X(03)00042-3.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"4353_CR14","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1210\/jcem.85.7.6661","volume":"85","author":"A Katz","year":"2000","unstructured":"Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G, et al. Quantitative insulin sensitivity check index. J Clin Endocrinol Metab. 2000;85:2402\u201310. https:\/\/doi.org\/10.1210\/jcem.85.7.6661.","journal-title":"J Clin Endocrinol Metab"},{"key":"4353_CR15","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.2337\/diacare.22.9.1462","volume":"22","author":"M Matsuda","year":"1999","unstructured":"Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from OGTT. Diabetes Care. 1999;22:1462\u201370. https:\/\/doi.org\/10.2337\/diacare.22.9.1462.","journal-title":"Diabetes Care"},{"key":"4353_CR16","doi-asserted-by":"publisher","first-page":"295","DOI":"10.2337\/diacare.23.3.295","volume":"23","author":"M Stumvoll","year":"2000","unstructured":"Stumvoll M, Mitrakou A, Pimenta W, Jenssen T, Yki-Jarvinen H, Van Haeften T, et al. Use of OGTT to assess \u03b2-cell function. Diabetes Care. 2000;23:295\u2013301. https:\/\/doi.org\/10.2337\/diacare.23.3.295.","journal-title":"Diabetes Care"},{"key":"4353_CR17","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1210\/jc.2002-021159","volume":"88","author":"S Soonthornpun","year":"2003","unstructured":"Soonthornpun S, Setasuban W, Thamprasit A, Chayanunnukul W, Rattarasarn C, Geater A. Novel insulin sensitivity index. J Clin Endocrinol Metab. 2003;88:1019\u201323. https:\/\/doi.org\/10.1210\/jc.2002-021159.","journal-title":"J Clin Endocrinol Metab"},{"key":"4353_CR18","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/S0140-6736(95)92131-5","volume":"346","author":"MH Duncan","year":"1995","unstructured":"Duncan MH, Singh BM, Wise PH, Carter G, Alaghband-Zadeh J. A simple measure of insulin resistance. Lancet. 1995;346:120\u20131. https:\/\/doi.org\/10.1016\/S0140-6736(95)92131-5.","journal-title":"Lancet"},{"key":"4353_CR19","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1373\/clinchem.2016.257436","volume":"62","author":"K Paulmichl","year":"2016","unstructured":"Paulmichl K, Hatunic M, Hojlund K, Jotic A, Krebs M, Mitrakou A, et al. Modification and validation of the triglyceride-to-HDL cholesterol ratio as a surrogate of insulin sensitivity in white juveniles and adults without diabetes mellitus: the single point insulin sensitivity estimator (SPISE). Clin Chem. 2016;62:1211\u20139. https:\/\/doi.org\/10.1373\/clinchem.2016.257436.","journal-title":"Clin Chem"},{"key":"4353_CR20","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s40618-021-01612-6","volume":"45","author":"I Barchetta","year":"2022","unstructured":"Barchetta I, Dule S, Bertoccini L, Cimini FA, Sentinelli F, Bailetti D, et al. The single-point insulin sensitivity estimator (SPISE) index is a strong predictor of abnormal glucose metabolism in overweight\/obese children: a long-term follow-up study. J Endocrinol Invest. 2022;45:43\u201351. https:\/\/doi.org\/10.1007\/s40618-021-01612-6.","journal-title":"J Endocrinol Invest"},{"issue":"4","key":"4353_CR21","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1136\/jmg.2009.071365","volume":"47","author":"HM Harville","year":"2010","unstructured":"Harville HM, Held S, Diaz-Font A, Davis EE, Diplas BH, Lewis RA, Borochowitz ZU, Zhou W, Chaki M, MacDonald J, Kayserili H, Beales PL, Katsanis N, Otto E, Hildebrandt F. Identification of 11 novel mutations in eight BBS genes by high-resolution homozygosity mapping. J Med Genet. 2010;47(4):262\u20137. https:\/\/doi.org\/10.1136\/jmg.2009.071365.","journal-title":"J Med Genet"},{"issue":"8","key":"4353_CR22","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1093\/hmg\/10.8.865","volume":"10","author":"DY Nishimura","year":"2001","unstructured":"Nishimura DY, Searby CC, Carmi R, Elbedour K, Van Maldergem L, Fulton AB, Lam BL, Powell BR, Swiderski RE, Bugge KE, Haider NB, Kwitek-Black AE, Ying L, Duhl DM, Gorman SW, Heon E, Iannaccone A, Bonneau D, Biesecker LG, Jacobson SG, Sheffield VC. Positional cloning of a novel gene on chromosome 16q causing Bardet-Biedl syndrome (BBS2). Hum Mol Genet. 2001;10(8):865\u201374.","journal-title":"Hum Mol Genet"},{"issue":"6","key":"4353_CR23","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1002\/humu.21480","volume":"32","author":"C Deveault","year":"2011","unstructured":"Deveault C, Billingsley G, Duncan JL, Bin J, Theal R, Vincent A, Fieggen KJ, Gerth C, Noordeh N, Traboulsi EI, Fishman GA, Chitayat D, Knueppel T, Mill\u00e1n JM, Munier FL, Kennedy D, Jacobson SG, Innes AM, Mitchell GA, Boycott K, H\u00e9on E. BBS genotype-phenotype assessment of a multiethnic patient cohort calls for a revision of the disease definition. Hum Mutat. 2011;32(6):610\u20139. https:\/\/doi.org\/10.1002\/humu.21480.","journal-title":"Hum Mutat"},{"issue":"5","key":"4353_CR24","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.mcp.2015.05.008","volume":"29","author":"C Knopp","year":"2015","unstructured":"Knopp C, Rudnik-Sch\u00f6neborn S, Eggermann T, Bergmann C, Begemann M, Schoner K, Zerres K, Ortiz Br\u00fcchle N. Syndromic ciliopathies: From single gene to multi gene analysis by SNP arrays and next generation sequencing. Mol Cell Probes. 2015;29(5):299\u2013307.","journal-title":"Mol Cell Probes"},{"issue":"1","key":"4353_CR25","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/ahg.12401","volume":"85","author":"E Gumus","year":"2021","unstructured":"Gumus E, Tuncez E, Oz O, Saka Guvenc M. Clinical and exome sequencing findings in seven children with Bardet-Biedl syndrome from Turkey. Ann Hum Genet. 2021;85(1):27\u201336. https:\/\/doi.org\/10.1111\/ahg.12401.","journal-title":"Ann Hum Genet"},{"issue":"9","key":"4353_CR26","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1136\/jmedgenet-2018-1053","volume":"55","author":"L Kleinendorst","year":"2018","unstructured":"Kleinendorst L, Massink MPG, Cooiman MI, Savas M, van der Baan-Slootweg OH, Roelants RJ, Janssen ICM, Meijers-Heijboer HJ, Knoers NVAM, van Ploos HK, van Rossum EFC, van den Akker ELT, van Haaften G, van der Zwaag B, van Haelst MM. Genetic obesity: next-generation sequencing results of 1230 patients with obesity. J Med Genet. 2018;55(9):578\u201386. https:\/\/doi.org\/10.1136\/jmedgenet-2018-1053.","journal-title":"J Med Genet"},{"issue":"Suppl 2","key":"4353_CR27","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/dom.15480","volume":"26","author":"JW Tomlinson","year":"2024","unstructured":"Tomlinson JW. Bardet-Biedl syndrome: A focus on genetics, mechanisms and metabolic dysfunction. Diabetes Obes Metab. 2024;26(Suppl 2):13\u201324. https:\/\/doi.org\/10.1111\/dom.15480. Epub 2024 Feb 1.","journal-title":"Diabetes Obes Metab"},{"issue":"10","key":"4353_CR28","doi-asserted-by":"publisher","first-page":"e3271","DOI":"10.1210\/clinem\/dgaf079","volume":"110","author":"AM Haqq","year":"2025","unstructured":"Haqq AM, Poitou C, Chung WK, Forsythe E, Conroy R, Dollfus H, Malhotra S, Touchot N, Okorie U, Beales P, Cl\u00e9ment K, Argente J. Impact of Setmelanotide on Metabolic Syndrome Risk in Patients With Bardet-Biedl Syndrome. J Clin Endocrinol Metab. 2025;110(10):e3271\u201382. https:\/\/doi.org\/10.1210\/clinem\/dgaf079.","journal-title":"J Clin Endocrinol Metab"},{"key":"4353_CR29","doi-asserted-by":"crossref","unstructured":"Cho W, Seo MW, Rosenberg J, Kim JY. Single point insulin sensitivity estimator index for identifying metabolic syndrome in US adults: NHANES 2017-march 2020. Obes Res Clin Pract. 2024 Jul-Aug;18(4):280\u20135. Epub 2024 Aug 12.","DOI":"10.1016\/j.orcp.2024.08.002"},{"key":"4353_CR30","doi-asserted-by":"publisher","first-page":"1439901","DOI":"10.3389\/fendo.2024.1439901","volume":"15","author":"G Tantari","year":"2024","unstructured":"Tantari G, Bassi M, Pistorio A, Minuto N, Napoli F, Piccolo G, La Valle A, Spacco G, Cervello C, D\u2019Annunzio G, Maghnie M. SPISE INDEX (Single point insulin sensitivity estimator): indicator of insulin resistance in children and adolescents with overweight and obesity. Front Endocrinol (Lausanne). 2024;15:1439901. https:\/\/doi.org\/10.3389\/fendo.2024.1439901.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"11","key":"4353_CR31","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1038\/s41431-024-01634-7","volume":"32","author":"H Dollfus","year":"2024","unstructured":"Dollfus H, Lilien MR, Maffei P, Verloes A, Muller J, Bacci GM, Cetiner M, van den Akker ELT, Grudzinska Pechhacker M, Testa F, Lacombe D, Stokman MF, Simonelli F, Gouronc A, Gavard A, van Haelst MM, Koenig J, Rossignol S, Bergmann C, Zacchia M, Leroy BP, Mosbah H, Van Eerde AM, Mekahli D, Servais A, Poitou C, Valverde D. Bardet-Biedl syndrome improved diagnosis criteria and management: Inter European Reference Networks consensus statement and recommendations. Eur J Hum Genet. 2024;32(11):1347\u201360. https:\/\/doi.org\/10.1038\/s41431-024-01634-7. Epub 2024 Jul 31.","journal-title":"Eur J Hum Genet"},{"issue":"1","key":"4353_CR32","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s12902-025-01957-6","volume":"25","author":"A Azarboo","year":"2025","unstructured":"Azarboo A, Fallahtafti P, Jalali S, Shirinezhad A, Assempoor R, Ghaseminejad-Raeini A. Screening accuracy of Single-Point Insulin Sensitivity Estimator (SPISE) for metabolic syndrome: a systematic review and meta-analysis. BMC Endocr Disord. 2025;25(1):142. https:\/\/doi.org\/10.1186\/s12902-025-01957-6.","journal-title":"BMC Endocr Disord"},{"key":"4353_CR33","doi-asserted-by":"publisher","unstructured":"H\u00fchne T, Polichronidou IM, Finkelberg I, Brensing P, Jaegers J, Dinkelbach L, Kiewert C, Galetzka W, Huessler EM, Scherer T, B\u00f6kenkamp A, G\u00e4ckler A, Pape L, Cetiner M. Impact of the melanocortin-4 receptor agonist setmelanotide on MASLD and kidney function in Bardet-Biedl syndrome. J Clin Endocrinol Metab 2025 Sep 4:dgaf483. https:\/\/doi.org\/10.1210\/clinem\/dgaf483. Epub ahead of print.","DOI":"10.1210\/clinem\/dgaf483"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-026-04353-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-026-04353-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-026-04353-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T23:26:32Z","timestamp":1785972392000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13023-026-04353-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,6]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4353"],"URL":"https:\/\/doi.org\/10.1186\/s13023-026-04353-y","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,6]]},"assertion":[{"value":"19 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol was approved by the Institutional Ethics Committee of Istanbul Faculty of Medicine (Approval No: 2023\/2076). Written informed consent was obtained from parents or legal guardians of all participants, in accordance with the Declaration of Helsinki.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"266"}}